Profound Medical Corp.
PRN.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 251.15% | 0.67% | -79.19% | -80.39% | -80.39% |
| Total Other Revenue | 25.60% | 20.10% | 33.22% | 45.52% | 37.03% |
| Total Revenue | 39.35% | 16.67% | 1.00% | 7.75% | 0.39% |
| Cost of Revenue | 33.02% | 7.46% | -16.81% | -23.03% | -25.93% |
| Gross Profit | 43.53% | 23.36% | 16.85% | 45.05% | 31.19% |
| SG&A Expenses | 35.69% | 18.19% | 9.27% | 3.84% | -16.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.13% | 11.51% | 0.51% | -1.29% | -17.43% |
| Operating Income | -26.61% | -10.25% | -0.38% | 3.33% | 20.89% |
| Income Before Tax | -8.67% | 1.96% | -4.73% | -1.11% | 1.28% |
| Income Tax Expenses | -97.72% | -147.06% | -145.07% | -144.60% | 514.00% |
| Earnings from Continuing Operations | -7.55% | 3.60% | -3.06% | 0.35% | 0.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.55% | 3.60% | -3.06% | 0.35% | 0.40% |
| EBIT | -26.61% | -10.25% | -0.38% | 3.33% | 20.89% |
| EBITDA | -27.81% | -10.98% | -1.41% | 1.90% | 20.15% |
| EPS Basic | 3.67% | 10.91% | 1.83% | 2.17% | 1.65% |
| Normalized Basic EPS | -6.86% | 0.42% | -10.15% | -8.92% | 11.11% |
| EPS Diluted | 3.67% | 10.91% | 1.83% | 2.17% | 1.65% |
| Normalized Diluted EPS | -6.86% | 0.42% | -10.15% | -8.92% | 11.11% |
| Average Basic Shares Outstanding | 12.31% | 9.02% | 5.73% | 1.87% | 1.40% |
| Average Diluted Shares Outstanding | 12.31% | 9.02% | 5.73% | 1.87% | 1.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
